To include your compound in the COVID-19 Resource Center, submit it here.

EIB backs development of AntibioTx anti-infective

AntibioTx A/S (Hellerup, Denmark) will receive €20 million ($23.2 million) from a tranched financing with the European Investment Bank to support

Read the full 215 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE